Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Renalytix Plc (RENX) Share Price

Price 6.75p on 03-12-2025 at 06:00:09
Change 0.00p 0%
Buy 0.00p
Sell 0.00p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Sell 200,000.00 at 6.735p
Day's Volume: 0
Last Close: 6.75p
Open: 0.00p
ISIN: GB00BYWL4Y04
Day's Range 0.00p - 0.00p
52wk Range: 5.75p - 12.50p
Market Capitalisation: £29.50m
VWAP: 0.00p
Shares in Issue: 437.02m

Sector: Health Care and Related Services

Listed In: FTSE AIM All-Share,

Renalytix Plc (RENX) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 200,000 6.735p Ordinary
 16:40:56 - 02-Dec-25
Sell* 54,000 6.635p Ordinary
 15:44:40 - 02-Dec-25
Sell* 48,784 6.74p Ordinary
 15:42:12 - 02-Dec-25
Sell* 86,053 6.74p Ordinary
 13:05:58 - 02-Dec-25
Sell* 1,031 6.625p Ordinary
 12:23:13 - 02-Dec-25
Sell* 227 6.74p Ordinary
 11:07:30 - 02-Dec-25
Sell* 10 6.625p Ordinary
 11:02:45 - 02-Dec-25
Sell* 14,500 6.635p Ordinary
 11:02:39 - 02-Dec-25
Unknown* 15,000 6.75p Ordinary
 10:03:04 - 02-Dec-25
Sell* 42,575 6.635p Ordinary
 09:21:16 - 02-Dec-25
See more Renalytix Plc trades

Renalytix Plc (RENX) Share Price History

Time period:
to
Date Open High Low Close Volume
3rd Dec 2025 (Wed) 6.75 6.75 6.75 6.75 0
2nd Dec 2025 (Tue) 6.75 6.48 6.48 6.75 486,240
1st Dec 2025 (Mon) 6.75 6.75 6.75 6.75 0
28th Nov 2025 (Fri) 6.75 6.75 6.75 6.75 908,446
27th Nov 2025 (Thu) 6.75 6.75 6.75 6.75 152,639
26th Nov 2025 (Wed) 6.75 6.75 6.75 6.75 420,097
25th Nov 2025 (Tue) 6.75 6.75 6.75 6.75 567,166
24th Nov 2025 (Mon) 6.75 6.75 6.75 6.75 466,695
21st Nov 2025 (Fri) 6.75 6.75 6.75 6.75 593,437
20th Nov 2025 (Thu) 6.75 6.75 6.75 6.75 175,310
19th Nov 2025 (Wed) 7.25 7.25 6.75 6.75 546,436
18th Nov 2025 (Tue) 7.25 7.25 7.25 7.25 583,436
17th Nov 2025 (Mon) 6.85 7.25 6.85 7.25 900,611
14th Nov 2025 (Fri) 6.85 6.85 6.85 6.85 98,310
13th Nov 2025 (Thu) 6.85 6.85 6.85 6.85 296,406
12th Nov 2025 (Wed) 7.50 7.50 6.85 6.85 812,590
11th Nov 2025 (Tue) 7.25 7.25 7.15 7.25 336,223
10th Nov 2025 (Mon) 7.15 7.25 7.00 7.25 582,674
7th Nov 2025 (Fri) 7.15 7.15 6.90 7.15 714,945
6th Nov 2025 (Thu) 7.25 7.15 6.75 7.15 2,796,075
5th Nov 2025 (Wed) 7.25 7.25 7.25 7.25 691,010
4th Nov 2025 (Tue) 7.25 7.25 6.75 7.25 4,873,246
3rd Nov 2025 (Mon) 8.25 7.38 7.38 7.38 5,403,577
See more Renalytix Plc price history

Renalytix Plc (RENX) Regulatory News

Date Source Headline
27th Nov 2025 2:39 pm RNS Holding(s) in Company
25th Nov 2025 3:44 pm RNS Holding(s) in Company
25th Nov 2025 7:00 am RNS Plan to Implement ADS Ratio Change
12th Nov 2025 7:00 am RNS Pivotal kidneyintelX.dkd data published
5th Nov 2025 4:02 pm RNS Holding(s) in Company
4th Nov 2025 6:05 pm RNS Publication of Annual Report & Notice of AGM
3rd Nov 2025 12:05 pm RNS Holding(s) in Company
3rd Nov 2025 7:00 am RNS Audited Full Year Fiscal 2025 Results
30th Oct 2025 4:58 pm RNS Holding(s) in Company
28th Oct 2025 4:04 pm RNS Holding(s) in Company
See more Renalytix Plc regulatory news

Renalytix Plc (RENX) Share News

IN BRIEF: Aquila European Renewables appoints Robert Naylor as chair

28th Nov 2025 16:10

Aquila European Renewables PLC - managed by Aquila Capital, invests in European renewable energy assets - Appoints Robert Naylor as non-executive chair, effective Friday this week. Confirms Non-Executive Chair Ian Nolan has retired from the board as of Thursday, having served in his role since prior to the IPO in 2019. Aquila highlights Naylor's 29 years of experience in capital markets, with him specialising in the investment trusts sector. Notes his current position as lead fund manager at Achilles Investment Company Ltd, and NED at PRS REIT PLC, Niox Group PLC and Renalytix PLC. Read More

TRADING UPDATES: Celsius raises funds; Built Cybernetics acquisition

12th Nov 2025 15:40

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

IN BRIEF: Renalytix loss narrows as costs down amid fewer employees

3rd Nov 2025 12:20

Renalytix PLC - London-based diagnostics company - Pretax loss narrows to USD21.8 million in the financial year ended June 30, from USD45.5 million a year prior. Revenue climbs 30% to USD3.0 million from USD2.3 million, with the company citing revenue growth across all revenue streams, as well as additional integration with a large physician practice in New York and increased pharma services revenue from global pharma leaders. Administrative costs reduce by 40% to USD18.4 million from USD30.7 million. This was "driven by headcount and operations optimization, delisting from NASDAQ, and the regaining foreign private issuer status. While reorganisation and delisting costs were higher than anticipated, the resulting reduction has provided a lower, predictable cash burn profile." Looking ahead, Renalytix says it continued to strengthen its presence in its initial three target states of Florida, Texas and New York. The company expects to announce additional complimentary strategic agreements in the current financial year running til the end of June 2026. Read More

TRADING UPDATES: Light Science contract win; One Health sales jump

27th Oct 2025 15:45

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

IN BRIEF: Renalytix gets USD4 million balance sheet boost

10th Oct 2025 18:14

Renalytix PLC - London-based diagnostics company - Reports Heights Capital Ireland LLC-advised fund notifies company that approximately USD4 million of non-amortising senior convertible bonds will be capitalised. Says 31.7 million ordinary shares will be issued at 9.5 pence each, the same price as Renalytix's recent fundraise, which raised just over GBP1.0 million. Renalytix says the bond conversion will improve its debt-to-equity ratio and significantly improve its balance sheet, improving its net asset position by around USD4 million and saving up to USD1.4 million in accrued interest over the remaining life of the loan. Read More

See more Renalytix Plc news
FTSE 100 Latest
Value9,701.80
Change0.00

Login to your account

Forgot Password?

Not Registered